ÌÇÐÄVlog

Annemarie C. Brescia, MD

Rheumatology

Primary Office

¾Ã¾Ã¾Ã¾Ã¾Ã¾Ã¾Ã¾«Æ· Children's Hospital, Delaware ¾Ã¾Ã¾Ã¾Ã¾Ã¾Ã¾Ã¾«Æ· Children's Hospital, Delaware 1600 Rockland Road Wilmington, DE 19803 Appointment: (800) 416-4441

Education & Training

Fellowship

  • Pediatric Rheumatology - ¾Ã¾Ã¾Ã¾Ã¾Ã¾Ã¾Ã¾«Æ·/Alfred I. duPont Hospital for Children, 2004

Residency

  • Pediatrics - St. Christopher's Hospital for Children, 2001

Medical/Dental School

  • M.D. - New York University, 1998

Board Certifications

  • American Board of Pediatrics/General Pediatrics
  • American Board of Pediatrics/Pediatric Rheumatology

Awards & Recognition

  • 2014 Delaware Today magazine, Top Doctors

Insurance Accepted

  • Aetna Better Health PA Kids HMO
  • Aetna HMO
  • Aetna PPO/POS/EPO
  • Amerihealth Caritas Delaware
  • Amerihealth Caritas Delaware Next
  • Carefirst MD Community Health Plan Mcaid
  • Cigna Lifesource Transplant
  • Cigna/Great West HMO EPO POS
  • Cigna/Great West PPO
  • Delaware Medicaid/Diamond State
  • Delaware Medicare
  • Devon Health Services
  • Fidelis Care NJ Medicaid HMO
  • First Health/Affordable PPO
  • Geisinger Health Plan Commercial
  • Global Medical Managment DE/PA
  • Health Partners Medicaid/Kidz Partner HMO
  • Highmark Blue Cross Blue Shield of Delaware
  • Highmark Medicaid Health Options
  • Horizon Blue Cross Blue Shield of New Jersey
  • Independance Blue Cross/Amerihealth/Keystone Health Plan
  • Insurance Administrators of America
  • INTEGRA Administrative Group (ClaimsBridge)
  • Keystone First Medicaid HMO
  • Lifetrac Transplant
  • Maryland Medicaid
  • Multiplan PPO
  • National Transplant (Humana)
  • New Jersey Medicaid
  • Pennsylvania Medicaid
  • Plan Vista/NPPN PPO
  • Preferred Healthcare PPO
  • Private Health Care Systems (PHCS)
  • Qualcare HMO/POS/PPO
  • Tricare/Humana Military Health Services/CHAMPVA
  • United Healthcare of the Mid-Atlantic
  • UPMC MCAID/CHIP PA DE
  • US Family Health Plan
  • Wellpoint Maryland Medcaid

  • Juvenile Idiopathic Arthritis
  • Juvenile Rheumatoid Arthritis

  • Methotrexate inhibits BMP4 and abrogates the hypertrophic chondrocyte phenotype of synovial fibroblasts in juvenile idiopathic arthritis; Pediatric Rheumatology; (2024).

  • CCL24, CXCL9 and CXCL10 are increased in synovial fluid in patients with juvenile idiopathic arthritis requiring advanced treatment; Rheumatology (United Kingdom); (2023).

  • Adalimumab Effectively Decreases Inflammation Downstream of TNFα Signaling in Synoviocytes from Extended Oligoarticular Juvenile Idiopathic Arthritis; Rheumatology and Therapy; (2023).

  • Single-cell analysis reveals heterogeneity of juvenile idiopathic arthritis fibroblast-like synoviocytes with implications for disease subtype; Arthritis Research and Therapy; (2022).

  • An Atypical Case of Scurvy in an Adolescent With Sacroiliitis; Clinical Pediatrics; (2022).

  • The culture microenvironment of juvenile idiopathic arthritis synovial fibroblasts is favorable for endochondral bone formation through BMP4 and repressed by chondrocytes; Pediatric Rheumatology; (2021).

  • Juvenile idiopathic arthritis fibroblast-like synoviocytes influence chondrocytes to alter BMP antagonist expression demonstrating an interaction between the two prominent cell types involved in endochondral bone formation; Pediatric Rheumatology; (2020).

  • Juvenile Idiopathic Arthritis Fibroblast-like Synoviocytes, through BMP signaling, play a central role in joint growth disturbances; Research Square; (2020).

  • Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases; Journal of Clinical Investigation; (2020).

  • Prior to extension, transcriptomes of fibroblast-like synoviocytes from extended and polyarticular juvenile idiopathic arthritis are indistinguishable; Pediatric Rheumatology; (2018).

  • Unilateral Periorbital Swelling in Two Previously Healthy Females; Global Pediatric Health; (2017).

  • Secretion of pro-inflammatory cytokines and chemokines and loss of regulatory signals by fibroblast-like synoviocytes in juvenile idiopathic arthritis; Proteomics - Clinical Applications; (2017).

  • The role of transforming growth factor β signaling in fibroblast-like synoviocytes from patients with oligoarticular juvenile idiopathic arthritis: dysregulation of transforming growth factor β signaling, including overexpression of bone morphogenetic protein 4, may lead to a chondrocyte phenotype and may contribute to bony hypertrophy.; Arthritis & rheumatology (Hoboken, N.J.); (2014).

  • Lyme chondritis presenting as painless ear erythema; Pediatrics; (2013).

  • Prognostic Impact of Atypical Presentation in Pediatric Systemic Lupus Erythematosus: Results from a Multicenter Study; Journal of Pediatrics; (2010).

  • Prolonged synovitis in pediatric lyme arthritis cannot be predicted by clinical or laboratory parameters; Clinical Rheumatology; (2009).

  • Focus on Subspecialties, Importance of Immunizations:; AAP News; (2009).

  • Predicting duration of beneficial effect of joint injection among children with chronic arthritis by measuring biomarkers concentration in synovial fluid at the time of injection; Clinical and Experimental Rheumatology; (2008).

  • Steady improvement of prothrombin levels after cyclophosphamide therapy in pediatric lupus anticoagulant hypoprothrombinemia syndrome (LAHPS); Clinical Rheumatology; (2007).

  • Joint Swelling; Pediatrics on Call; (2006).

  • Process for the Prepartion of Bis(Amidocarboxylic Acid); Unknown Source; (1995).

  • Process for the Preparation of Bis(Amidocarboxylic Acids); Unknown Source; (1995).

  • One-pot synthesis of cyclic amidinium tetrafluoroborates and hexafluorophosphates; the simplest models of N5, N10-methenyl-tetrahydrofolate coenzyme; Tetrahedron Letters; (1991).

  • English